| Q34385523 | A bacterial toxin inhibits DNA replication elongation through a direct interaction with the β sliding clamp. |
| Q41050594 | AAA+ Machines of Protein Destruction in Mycobacteria |
| Q89826547 | Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in vitro |
| Q38829284 | Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections |
| Q40776051 | Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease |
| Q89983079 | An allosteric switch regulates Mycobacterium tuberculosis ClpP1P2 protease function as established by cryo-EM and methyl-TROSY NMR |
| Q27314706 | An essential nonredundant role for mycobacterial DnaK in native protein folding |
| Q42709358 | Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase |
| Q36243182 | Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge |
| Q39023951 | Bacterial proteases, untapped antimicrobial drug targets |
| Q38047828 | Bacterial proteolytic complexes as therapeutic targets |
| Q33607221 | Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome. |
| Q55379024 | Cdc48-like protein of actinobacteria (Cpa) is a novel proteasome interactor in mycobacteria and related organisms. |
| Q37282173 | Chromosomal rearrangements and protein globularity changes in Mycobacterium tuberculosis isolates from cerebrospinal fluid |
| Q35536311 | Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity |
| Q34371280 | Cloning and characterization of Clp protease proteolytic subunit 2 and its implication in clinical diagnosis of tuberculosis |
| Q58558556 | Clostridium difficile ClpP Homologs are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide Modulation |
| Q64955662 | ClpP Protease, a Promising Antimicrobial Target. |
| Q42595177 | Comparative genomic analysis of twelve Streptococcus suis (pro)phages |
| Q92372002 | Comparative proteomics analysis between biofilm and planktonic cells of Mycobacterium tuberculosis |
| Q93067396 | Consequences of the loss of catalytic triads in chloroplast CLPPR protease core complexes in vivo |
| Q34442361 | Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery |
| Q64118325 | Defining the Transcriptional and Post-transcriptional Landscapes of in Aerobic Growth and Hypoxia |
| Q90450055 | Development of high throughput screening methods for inhibitors of ClpC1P1P2 from Mycobacteria tuberculosis |
| Q39019430 | Development of new antituberculosis drugs from natural products |
| Q54229844 | Domains within RbpA serve specific functional roles that regulate the expression of distinct mycobacterial gene subsets. |
| Q40422721 | Effects of Increasing the Affinity of CarD for RNA Polymerase on Mycobacterium tuberculosis Growth, rRNA Transcription, and Virulence. |
| Q41927049 | Enabling faster Go/No-Go decisions through secondary screens in anti-mycobacterial drug discovery |
| Q33709564 | Enhanced specialized transduction using recombineering in Mycobacterium tuberculosis |
| Q38195069 | Genomic tools to profile antibiotic mode of action. |
| Q51607347 | Inhibitory Effect of Camptothecin against Rice Bacterial Brown Stripe Pathogen Acidovorax avenae subsp. avenae RS-2. |
| Q92949154 | Insights to the Assembly of a Functionally Active Leptospiral ClpP1P2 Protease Complex along with Its ATPase Chaperone ClpX |
| Q36569233 | Integration-dependent bacteriophage immunity provides insights into the evolution of genetic switches |
| Q27682707 | Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2 |
| Q38660358 | Mechanistic insights into bacterial AAA+ proteases and protein-remodelling machines |
| Q37703346 | Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease |
| Q64289426 | Mycobacterium smegmatis HtrA Blocks the Toxic Activity of a Putative Cell Wall Amidase |
| Q34656348 | Mycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit different substrate specificities |
| Q36492775 | Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis. |
| Q28538895 | Mycobacterium tuberculosis Hip1 modulates macrophage responses through proteolysis of GroEL2 |
| Q38949083 | Mycobacterium tuberculosis Prolyl Oligopeptidase Induces In vitro Secretion of Proinflammatory Cytokines by Peritoneal Macrophages. |
| Q27675886 | Mycobacterium tuberculosis RsdA provides a conformational rationale for selective regulation of -factor activity by proteolysis |
| Q47395522 | New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State |
| Q91807571 | New tuberculosis drug targets, their inhibitors, and potential therapeutic impact |
| Q35113287 | Post-translational regulation via Clp protease is critical for survival of Mycobacterium tuberculosis. |
| Q47576680 | Proteases and protease inhibitors in infectious diseases |
| Q38103940 | Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets |
| Q35038408 | Protein-coding housekeeping gene Rv2461c can be used as an amplification target in loop-mediated isothermal amplification assay for the detection of Mycobacterium tuberculosis in sputum samples |
| Q38600486 | RETRACTED: Targeting Mycobacterial Enzymes with Natural Products |
| Q38547127 | Recently disclosed chemical entities as potential candidates for management of tuberculosis |
| Q34626585 | Regulated Expression Systems for Mycobacteria and Their Applications |
| Q57751886 | Reversible inhibition of the ClpP protease via an N-terminal conformational switch |
| Q47118931 | Stressed mycobacteria use the chaperone ClpB to sequester irreversibly oxidized proteins asymmetrically within and between cells |
| Q27679912 | Structural Basis of Mycobacterial Inhibition by Cyclomarin A |
| Q27678774 | Structural and functional insights into caseinolytic proteases reveal an unprecedented regulation principle of their catalytic triad |
| Q36755029 | Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis |
| Q42788863 | Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase |
| Q34624840 | Substrate specificity of MarP, a periplasmic protease required for resistance to acid and oxidative stress in Mycobacterium tuberculosis |
| Q35620201 | Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria |
| Q39149038 | Targeting Phenotypically Tolerant Mycobacterium tuberculosis |
| Q52692190 | Targeting the Proteostasis Network for Mycobacterial Drug Discovery. |
| Q92533100 | The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory clpP Gene as a Novel Antibiotic Resistance Factor |
| Q34531740 | The C-terminus of ClpC1 of Mycobacterium tuberculosis is crucial for its oligomerization and function |
| Q34551568 | The ClpP protease is required for the stress tolerance and biofilm formation in Actinobacillus pleuropneumoniae |
| Q35002980 | The Mycobacterium tuberculosis Clp gene regulator is required for in vitro reactivation from hypoxia-induced dormancy |
| Q35620145 | The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1 |
| Q36888447 | The Protease Locus of Francisella tularensis LVS Is Required for Stress Tolerance and Infection in the Mammalian Host |
| Q26795478 | The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis |
| Q35106042 | The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo |
| Q90425706 | The functional ClpXP protease of Chlamydia trachomatis requires distinct clpP genes from separate genetic loci |
| Q33601825 | Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome |
| Q40746718 | Two ways to skin a cat: acyldepsipeptides antibiotics can kill bacteria through activation or inhibition of ClpP activity |
| Q38053069 | Virulence factors of the Mycobacterium tuberculosis complex |